Delivery Order SPE2DH25D0001-SPE2D426F0131

Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense Medical Supply Chain on October 14, 2025, for CG8+ cartridges. The contract is structured as a fixed-price agreement with economic price adjustment provisions and does not utilize any set-aside designation, indicating full and open competition. Performance is scheduled for completion by October 16, 2025, at Abbott's facility in North Chicago, Illinois. This delivery order represents a continuation of Abbott's substantial presence in federal healthcare procurement, leveraging its established position as a leading supplier of diagnostic and point-of-care testing technologies to government agencies.

This award aligns with Abbott Laboratories' core business of supplying critical medical diagnostic equipment and consumables to federal healthcare systems, particularly the Department of Veterans Affairs and Defense Logistics Agency channels. The CG8+ cartridge delivery supports the company's extensive portfolio of immunoassay analyzers and point-of-care testing devices that are integral to clinical operations across federal medical facilities. As a child entity within Abbott's federal contracting structure, this delivery order likely derives from a larger Blanket Purchase Agreement or Indefinite Delivery Vehicle established under GSA Schedule contracts, enabling streamlined procurement of essential medical supplies for government healthcare operations.